Vecuronium Bromide

Norcuron

 

INDICATIONS:

  • Facilitates endotracheal intubation by paralysis of skeletal muscle
  • To increase pulmonary compliance during mechanical ventilation

 

ADMINISTRATION:

  • IV, IO

 

DOSAGE:

ADULT:

  • 0.1mg/kg over 30-60 seconds
  • Onset of 2-3 min., duration of 25-30 min.
  • Max 10 mg IV/IO

 

PEDIATRIC:

  • NOT INDICATED

 

THERAPEUTIC EFFECTS:

  • Prevents neuromuscular transmission by blocking the effect of acetylcholine at the myoneural junction
  • Skeletal muscle paralysis

 

RELATIVE CONTRAINDICATIONS:

  • Hypersensitivity to vecuronium

 

SIDE EFFECTS:

  • No side effects have occurred except with overdoses

 

SPECIAL NOTES / RESTRICTIONS:

  • Paralysis may be prolonged by succinylcholine, quinidine, and beta blockers

 

RSI MAY BE initiated by Standing Order or Protocol. It is RECOMMENDED – where feasible – that On-Line Medical Control be obtained prior to initiation – but this should not supercede the appropriate care of the patient.

  • 100% QI / PI is required for ALL RSI runs.